Nanoparticles traveled to different organs in the body depending on the type of protein coating applied, according to a recent study.
Yearly Archives: 2020
A novel heart failure drug called sacubitril-valsartan reduced the risk of hospitalizations for heart failure and death from cardiovascular causes more in women than in men, according to a study published in Circulation.
A new study has found cells with high numbers of centrioles more quickly migrated through layers of tissue, a process known as radial intercalation, which may provide new insights into the development of many cancers.
A new study has helped solve the mystery of how dysfunctional chromosome folding leads to cancer.
The elevated expression of a gene called LY6K was correlated with increased cancer cell growth and resistance to radiation therapy in glioblastoma, according to a recent Northwestern Medicine study.
Northwestern Medicine has enrolled its first participants in a new international clinical drug trial for COVID-19, testing remdesivir, a novel anti-viral drug developed to treat Ebola, and which has also shown antiviral activity in coronaviruses.
A new method of delivering radiation during whole brain radiotherapy could reduce neurotoxicity without compromising effectiveness, according to a new study.
A special COVID-19 testing team has been put in place at Northwestern, with the goal of at least quadrupling the number of tests processed at Northwestern Medicine hospitals — from about 90 per day to more than 350 per day — and in the process, greatly reducing test result turnaround times.
Nicholas Soulakis, PhD, is taking a leave of absence from the medical school to work as an epidemiologist in the Illinois Department of Public Health Office of Policy, Planning and Statistics.
Gary Noskin, MD, professor of Medicine in the Division of Infectious Diseases and chief medical officer at Northwestern Memorial Hospital, answers questions about how Northwestern’s clinical research team is responding to the COVID-19 pandemic.